Back to Search
Start Over
The administration of 10 microg/kg granulocyte colony-stimulating factor (G-CSF) alone results in a successful peripheral blood stem cell collection when previous mobilization with chemotherapy and hematopoietic growth factor failed
- Source :
- Leukemialymphoma. 34(1-2)
- Publication Year :
- 1999
-
Abstract
- Some heavily pretreated cancer patients fail to mobilize enough peripheral blood stem cells (PBSC) after stimulation with chemotherapy and hematopoietic growth factors. For these patients the best way to obtain an adequate PBSC collection is unknown. Here we report 6 heavily pretreated cancer patients who failed to mobilize sufficient PBSC after stimulation with chemotherapy and G-CSF 5 microg/kg/day. In these cases, we used G-CSF 10 microg/kg/day alone for six days at least 3 weeks after the last chemotherapy. After three consecutive leukaphereses starting on day 5, five patients had adequate PBSC collections. With 6 days of G-CSF 10 microg/kg/day alone, 2.8 x 10(6) (+/- 1) CD34+ cells/kg were collected. This was significantly higher than the number of CD34+ cells/kg collected after chemotherapy and G-CSF 5 microg/kg 0.3 x 10(6) (+/- 0.1) [P = 0.05]. Four patients received high-dose chemotherapy with PBSC support. Hematologic recovery observed in these patients was as expected. In conclusion, G-CSF 10 microg/kg alone can mobilize progenitor cells into peripheral blood when previous mobilization with chemotherapy and G-CSF 5 microg/kg fails.
- Subjects :
- Adult
Male
Cancer Research
medicine.medical_specialty
medicine.medical_treatment
Hematopoietic growth factor
Injections, Subcutaneous
Breast Neoplasms
Hematopoietic stem cell transplantation
Hematopoietic Cell Growth Factors
Gastroenterology
Drug Administration Schedule
Internal medicine
Antineoplastic Combined Chemotherapy Protocols
Granulocyte Colony-Stimulating Factor
medicine
Humans
Leukapheresis
Progenitor cell
Hematopoietic Stem Cell Mobilization
Chemotherapy
Dose-Response Relationship, Drug
business.industry
Lymphoma, Non-Hodgkin
Hematopoietic Stem Cell Transplantation
Hematology
Middle Aged
Combined Modality Therapy
Hodgkin Disease
Granulocyte colony-stimulating factor
Surgery
Haematopoiesis
Oncology
Female
business
Subjects
Details
- ISSN :
- 10428194
- Volume :
- 34
- Issue :
- 1-2
- Database :
- OpenAIRE
- Journal :
- Leukemialymphoma
- Accession number :
- edsair.doi.dedup.....a6447f5c113b11b55b4241b6ff031d9c